BioFabUSA, a program of ARMI, is a public-private partnership with more than 170 members, including companies, academic institutions and not-for profit organizations.
ARMI | BioFabUSA will exhibit and present at the Defense Manufacturing Conference (DMC) 2025, held March 30 – April 2, 2026 in Orlando, FL. As a national innovation institute, BioFabUSA will share cutting-edge biomanufacturing technologies that enhance readiness and resilience across the defense industrial base.
DMC is the Department of Defense’s premier event for advancing manufacturing technology and strengthening the defense supply chain. BioFabUSA’s participation underscores its role as a key enabler of scalable, secure, and strategic biomanufacturing solutions.
During DMC 2025, BioFabUSA will:
BioFabUSA’s technical team and program leaders will connect with stakeholders from government, academia, and industry to advance dual-use solutions for national security. The institute’s membership model, combined with its infrastructure and DoD-aligned programming, uniquely positions BioFabUSA to drive innovation at the intersection of biotechnology and defense. Our team will share updates on funded projects, public-private partnerships, and field-ready manufacturing platforms.
By participating in DMC 2025, BioFabUSA reinforces its commitment to strengthening the U.S. manufacturing base, supporting service members, and building sustainable pathways for biotechnology to enhance national resilience.
BioFabUSA, a program of ARMI, is a public-private partnership with more than 170 members, including companies, academic institutions and not-for profit organizations.
